Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Positive-control and Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety in Rupatifen Fumarate Capsules for the Seasonal Allergic Rhinitis Patients

NCT07711262 is registered in ClinicalTrials.gov with Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07711262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07711262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Positive-control and Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety in Rupatifen Fumarate Capsules for the Seasonal Allergic Rhinitis Patients
Lead sponsor
Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Recruiting
Start date
August 18, 2026
Completion date
December 31, 2027
Enrollment
550 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal allergic rhinitis